127 related articles for article (PubMed ID: 11796990)
21. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
[TBL] [Abstract][Full Text] [Related]
22. HIV/AIDS. HLA leaves its footprints on HIV.
McMichael A; Klenerman P
Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
[No Abstract] [Full Text] [Related]
23. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
[TBL] [Abstract][Full Text] [Related]
24. Nucleic acid-based immunization against HIV-I: induction of protective in vivo immune responses.
Wang B; Boyer JD; Ugen KE; Srikantan V; Ayyaroo V; Agadjanyan MG; Williams WV; Newman M; Coney L; Carrano R
AIDS; 1995; 9 Suppl A():S159-70. PubMed ID: 8819582
[No Abstract] [Full Text] [Related]
25. Prime-boost strategies in DNA vaccines.
Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
[TBL] [Abstract][Full Text] [Related]
26. DermaVir, a novel HIV immunisation technology.
Lori F; Trocio J; Bakare N; Kelly LM; Lisziewicz J
Vaccine; 2005 Mar; 23(17-18):2030-4. PubMed ID: 15755566
[TBL] [Abstract][Full Text] [Related]
27. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
28. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 neutralizing antibodies: how full is the bottle?
Moore JP; Burton DR
Nat Med; 1999 Feb; 5(2):142-4. PubMed ID: 9930854
[No Abstract] [Full Text] [Related]
30. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
Gorse GJ; Baden LR; Wecker M; Newman MJ; Ferrari G; Weinhold KJ; Livingston BD; Villafana TL; Li H; Noonan E; Russell ND;
Vaccine; 2008 Jan; 26(2):215-23. PubMed ID: 18055072
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
Bhardwaj N; Walker BD
Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
[No Abstract] [Full Text] [Related]
33. Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India.
Kumar S; Aggarwal P; Vajpayee M; Pandey RM; Seth P
Vaccine; 2006 Mar; 24(14):2585-93. PubMed ID: 16480792
[TBL] [Abstract][Full Text] [Related]
34. Measuring HIV-1-specific T cell immunity: how valid are current assays?
D'Souza MP; Altfeld M
J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092
[No Abstract] [Full Text] [Related]
35. Delaying the immune-suppressive function of regulatory T cells might enhance immune responses against HIV vaccines.
Immunotherapy; 2010 May; 2(3):301. PubMed ID: 20658753
[No Abstract] [Full Text] [Related]
36. HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy.
Ada GL; McElrath MJ
AIDS Res Hum Retroviruses; 1997 Feb; 13(3):205-10. PubMed ID: 9115805
[No Abstract] [Full Text] [Related]
37. Attenuated retrovirus vaccines and AIDS.
Marx PA
Science; 1995 Nov; 270(5239):1219-20; author reply 1220-2. PubMed ID: 7502054
[No Abstract] [Full Text] [Related]
38. HIV-vaccine research takes one step forward. and one step back.
Senior K
Lancet; 2002 Jan; 359(9302):235. PubMed ID: 11812568
[No Abstract] [Full Text] [Related]
39. What hope is there for an HIV vaccine?
Witten G
S Afr Med J; 2004 Oct; 94(10):831. PubMed ID: 15532757
[No Abstract] [Full Text] [Related]
40. The status of HIV/AIDS vaccines--1993.
Weber J
Ther Immunol; 1994 Apr; 1(2):95-100. PubMed ID: 7584488
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
